Skip to main content
Top
Published in: Abdominal Radiology 10/2023

Open Access 24-06-2023 | Metastasis | Hepatobiliary

Prediction of regional lymph node metastasis in intrahepatic cholangiocarcinoma: it’s not all about size

Authors: Johannes Kolck, Timo Alexander Auer, Thula Walter-Rittel, Clarissa Hosse, Aboelyazid Elkilany, Adrian Alexander Marth, Uwe Pelzer, Raphael Mohr, Felix Krenzien, Georg Lurje, Wenzel Schöning, Bernd Hamm, Dominik Geisel, Uli Fehrenbach

Published in: Abdominal Radiology | Issue 10/2023

Login to get access

Abstract

Objectives

Lymph node metastases (LNM) are frequent in patients with intrahepatic cholangiocarcinoma (iCC) and worsen their prognosis even after surgery. Our aim was to investigate the predictive value of lymph node (LN) short axis, the most common discriminator for identifying LNM in tumor-imaging and to develop a predictive model for regional LNM in iCC taking computed tomography (CT) features of extranodal disease into account.

Materials and methods

We enrolled 102 patients with pathologically proven iCC who underwent CT prior to hepatic resection and hilar lymph node dissection (LND) from 2005 to 2021. Two blinded radiologists assessed various imaging characteristics and LN diameters, which were analyzed by bivariate and multivariate logistic regression to develop a prediction model for LNM.

Results

Prevalence of LNM was high (42.4 %) and estimated survival was shorter in LN-positive patients (p = 0.07). An LN short axis diameter of ≥ 9 mm demonstrated the highest predictive power for LNM. Three additional, statistically significant imaging features, presence of intrahepatic metastasis (p = 0.003), hilar tumor infiltration (p = 0.003), and tumor growth along the liver capsule (p = 0.004), were integrated into a prediction model, which substantially outperformed use of LN axis alone in ROC analysis (AUC 0.856 vs 0.701).

Conclusions

LN diameter alone proved to be a relevant but unreliable imaging-marker for LNM prediction in iCC. Our proposed prognostic model, which additionally considers intrahepatic metastases and hilar and capsular infiltration, significantly improves discriminatory power. Hilar and capsular involvement might indicate direct tumor extension to lymphatic liver structures.
Literature
1.
go back to reference Banales JM, Cardinale V, Carpino G, Marzioni M, Andersen JB, Invernizzi P, et al. Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol. 2016;13(5):261-80.CrossRefPubMed Banales JM, Cardinale V, Carpino G, Marzioni M, Andersen JB, Invernizzi P, et al. Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol. 2016;13(5):261-80.CrossRefPubMed
3.
go back to reference Florio AA, Ferlay J, Znaor A, Ruggieri D, Alvarez CS, Laversanne M, et al. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012. Cancer. 2020;126(11):2666-78.CrossRefPubMed Florio AA, Ferlay J, Znaor A, Ruggieri D, Alvarez CS, Laversanne M, et al. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012. Cancer. 2020;126(11):2666-78.CrossRefPubMed
4.
go back to reference Bertuccio P, Malvezzi M, Carioli G, Hashim D, Boffetta P, El-Serag HB, et al. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma. J Hepatol. 2019;71(1):104-14.CrossRefPubMed Bertuccio P, Malvezzi M, Carioli G, Hashim D, Boffetta P, El-Serag HB, et al. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma. J Hepatol. 2019;71(1):104-14.CrossRefPubMed
5.
go back to reference Palmer WC, Patel T. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol. 2012;57(1):69-76.CrossRefPubMedPubMedCentral Palmer WC, Patel T. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol. 2012;57(1):69-76.CrossRefPubMedPubMedCentral
6.
go back to reference Khan SA, Tavolari S, Brandi G. Cholangiocarcinoma: Epidemiology and risk factors. Liver Int. 2019;39 Suppl 1:19-31.CrossRefPubMed Khan SA, Tavolari S, Brandi G. Cholangiocarcinoma: Epidemiology and risk factors. Liver Int. 2019;39 Suppl 1:19-31.CrossRefPubMed
7.
go back to reference Kim TS, Pak JH, Kim JB, Bahk YY. Clonorchis sinensis, an oriental liver fluke, as a human biological agent of cholangiocarcinoma: a brief review. BMB Rep. 2016;49(11):590-7.CrossRefPubMedPubMedCentral Kim TS, Pak JH, Kim JB, Bahk YY. Clonorchis sinensis, an oriental liver fluke, as a human biological agent of cholangiocarcinoma: a brief review. BMB Rep. 2016;49(11):590-7.CrossRefPubMedPubMedCentral
8.
go back to reference Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BJ, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001;234(4):507-17; discussion 17-9. Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BJ, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001;234(4):507-17; discussion 17-9.
9.
go back to reference Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg. 2008;248(1):84-96.CrossRefPubMed Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg. 2008;248(1):84-96.CrossRefPubMed
10.
go back to reference Squires MH, Cloyd JM, Dillhoff M, Schmidt C, Pawlik TM. Challenges of surgical management of intrahepatic cholangiocarcinoma. Expert Rev Gastroenterol Hepatol. 2018;12(7):671-81.CrossRefPubMed Squires MH, Cloyd JM, Dillhoff M, Schmidt C, Pawlik TM. Challenges of surgical management of intrahepatic cholangiocarcinoma. Expert Rev Gastroenterol Hepatol. 2018;12(7):671-81.CrossRefPubMed
12.
go back to reference Pavicevic S, Reichelt S, Uluk D, Lurje I, Engelmann C, Modest DP, et al. Prognostic and Predictive Molecular Markers in Cholangiocarcinoma. Cancers (Basel). 2022;14(4). Pavicevic S, Reichelt S, Uluk D, Lurje I, Engelmann C, Modest DP, et al. Prognostic and Predictive Molecular Markers in Cholangiocarcinoma. Cancers (Basel). 2022;14(4).
13.
go back to reference de Jong MC, Nathan H, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol. 2011;29(23):3140-5.CrossRefPubMed de Jong MC, Nathan H, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol. 2011;29(23):3140-5.CrossRefPubMed
14.
go back to reference Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Nicoli P, et al. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg. 2009;33(6):1247-54.CrossRefPubMed Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Nicoli P, et al. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg. 2009;33(6):1247-54.CrossRefPubMed
15.
go back to reference Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM. Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-analysis. JAMA Surg. 2014;149(6):565-74.CrossRefPubMed Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM. Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-analysis. JAMA Surg. 2014;149(6):565-74.CrossRefPubMed
16.
go back to reference Lee AJ, Chun YS. Intrahepatic cholangiocarcinoma: the AJCC/UICC 8th edition updates. Chin Clin Oncol. 2018;7(5):52. Lee AJ, Chun YS. Intrahepatic cholangiocarcinoma: the AJCC/UICC 8th edition updates. Chin Clin Oncol. 2018;7(5):52.
17.
go back to reference Zhang XF, Xue F, Dong DH, Weiss M, Popescu I, Marques HP, et al. Number and Station of Lymph Node Metastasis After Curative-intent Resection of Intrahepatic Cholangiocarcinoma Impact Prognosis. Ann Surg. 2021;274(6):e1187-e95.CrossRefPubMed Zhang XF, Xue F, Dong DH, Weiss M, Popescu I, Marques HP, et al. Number and Station of Lymph Node Metastasis After Curative-intent Resection of Intrahepatic Cholangiocarcinoma Impact Prognosis. Ann Surg. 2021;274(6):e1187-e95.CrossRefPubMed
18.
go back to reference Zhang XF, Pawlik TM. Response to the Comment on "Number and Station of Lymph Node Metastasis After Curative-intent Resection of Intrahepatic Cholangiocarcinoma Impact Prognosis". Ann Surg. 2021;274(6):e743.CrossRefPubMed Zhang XF, Pawlik TM. Response to the Comment on "Number and Station of Lymph Node Metastasis After Curative-intent Resection of Intrahepatic Cholangiocarcinoma Impact Prognosis". Ann Surg. 2021;274(6):e743.CrossRefPubMed
19.
go back to reference Sahara K, Tsilimigras DI, Merath K, Bagante F, Guglielmi A, Aldrighetti L, et al. Therapeutic Index Associated with Lymphadenectomy Among Patients with Intrahepatic Cholangiocarcinoma: Which Patients Benefit the Most from Nodal Evaluation? Ann Surg Oncol. 2019;26(9):2959-68.CrossRefPubMed Sahara K, Tsilimigras DI, Merath K, Bagante F, Guglielmi A, Aldrighetti L, et al. Therapeutic Index Associated with Lymphadenectomy Among Patients with Intrahepatic Cholangiocarcinoma: Which Patients Benefit the Most from Nodal Evaluation? Ann Surg Oncol. 2019;26(9):2959-68.CrossRefPubMed
20.
go back to reference Guglielmi A, Ruzzenente A, Campagnaro T, Valdegamberi A, Bagante F, Bertuzzo F, et al. Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma. J Gastrointest Surg. 2013;17(11):1917-28.CrossRefPubMed Guglielmi A, Ruzzenente A, Campagnaro T, Valdegamberi A, Bagante F, Bertuzzo F, et al. Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma. J Gastrointest Surg. 2013;17(11):1917-28.CrossRefPubMed
21.
go back to reference Joo I, Lee JM, Yoon JH. Imaging Diagnosis of Intrahepatic and Perihilar Cholangiocarcinoma: Recent Advances and Challenges. Radiology. 2018;288(1):7-13.CrossRefPubMed Joo I, Lee JM, Yoon JH. Imaging Diagnosis of Intrahepatic and Perihilar Cholangiocarcinoma: Recent Advances and Challenges. Radiology. 2018;288(1):7-13.CrossRefPubMed
22.
go back to reference Aherne EA, Pak LM, Goldman DA, Gonen M, Jarnagin WR, Simpson AL, et al. Intrahepatic cholangiocarcinoma: can imaging phenotypes predict survival and tumor genetics? Abdom Radiol (NY). 2018;43(10):2665-72.CrossRefPubMedPubMedCentral Aherne EA, Pak LM, Goldman DA, Gonen M, Jarnagin WR, Simpson AL, et al. Intrahepatic cholangiocarcinoma: can imaging phenotypes predict survival and tumor genetics? Abdom Radiol (NY). 2018;43(10):2665-72.CrossRefPubMedPubMedCentral
23.
go back to reference Saleh M, Virarkar M, Bura V, Valenzuela R, Javadi S, Szklaruk J, et al. Intrahepatic cholangiocarcinoma: pathogenesis, current staging, and radiological findings. Abdom Radiol (NY). 2020;45(11):3662-80.CrossRefPubMed Saleh M, Virarkar M, Bura V, Valenzuela R, Javadi S, Szklaruk J, et al. Intrahepatic cholangiocarcinoma: pathogenesis, current staging, and radiological findings. Abdom Radiol (NY). 2020;45(11):3662-80.CrossRefPubMed
24.
go back to reference Krenzien F, Nevermann N, Krombholz A, Benzing C, Haber P, Fehrenbach U, et al. Treatment of Intrahepatic Cholangiocarcinoma-A Multidisciplinary Approach. Cancers (Basel). 2022;14(2). Krenzien F, Nevermann N, Krombholz A, Benzing C, Haber P, Fehrenbach U, et al. Treatment of Intrahepatic Cholangiocarcinoma-A Multidisciplinary Approach. Cancers (Basel). 2022;14(2).
25.
go back to reference Benzing C, Krenzien F, Mieg A, Wolfsberger A, Andreou A, Nevermann N, et al. A tailored approach in lymph node-positive perihilar cholangiocarcinoma. Langenbecks Arch Surg. 2021;406(5):1499-509.CrossRefPubMedPubMedCentral Benzing C, Krenzien F, Mieg A, Wolfsberger A, Andreou A, Nevermann N, et al. A tailored approach in lymph node-positive perihilar cholangiocarcinoma. Langenbecks Arch Surg. 2021;406(5):1499-509.CrossRefPubMedPubMedCentral
26.
go back to reference Tsilimigras DI, Sahara K, Paredes AZ, Moro A, Mehta R, Moris D, et al. Predicting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma. J Gastrointest Surg. 2021;25(5):1156-63.CrossRefPubMed Tsilimigras DI, Sahara K, Paredes AZ, Moro A, Mehta R, Moris D, et al. Predicting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma. J Gastrointest Surg. 2021;25(5):1156-63.CrossRefPubMed
27.
go back to reference Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228-47.CrossRefPubMed Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228-47.CrossRefPubMed
28.
go back to reference Weber SM, Ribero D, O'Reilly EM, Kokudo N, Miyazaki M, Pawlik TM. Intrahepatic cholangiocarcinoma: expert consensus statement. HPB (Oxford). 2015;17(8):669-80.CrossRefPubMedPubMedCentral Weber SM, Ribero D, O'Reilly EM, Kokudo N, Miyazaki M, Pawlik TM. Intrahepatic cholangiocarcinoma: expert consensus statement. HPB (Oxford). 2015;17(8):669-80.CrossRefPubMedPubMedCentral
29.
go back to reference Bartsch F, Hahn F, Muller L, Baumgart J, Hoppe-Lotichius M, Kloeckner R, et al. Relevance of suspicious lymph nodes in preoperative imaging for resectability, recurrence and survival of intrahepatic cholangiocarcinoma. BMC Surg. 2020;20(1):75.CrossRefPubMedPubMedCentral Bartsch F, Hahn F, Muller L, Baumgart J, Hoppe-Lotichius M, Kloeckner R, et al. Relevance of suspicious lymph nodes in preoperative imaging for resectability, recurrence and survival of intrahepatic cholangiocarcinoma. BMC Surg. 2020;20(1):75.CrossRefPubMedPubMedCentral
30.
go back to reference Clark CJ, Wood-Wentz CM, Reid-Lombardo KM, Kendrick ML, Huebner M, Que FG. Lymphadenectomy in the staging and treatment of intrahepatic cholangiocarcinoma: a population-based study using the National Cancer Institute SEER database. HPB (Oxford). 2011;13(9):612-20.CrossRefPubMedPubMedCentral Clark CJ, Wood-Wentz CM, Reid-Lombardo KM, Kendrick ML, Huebner M, Que FG. Lymphadenectomy in the staging and treatment of intrahepatic cholangiocarcinoma: a population-based study using the National Cancer Institute SEER database. HPB (Oxford). 2011;13(9):612-20.CrossRefPubMedPubMedCentral
31.
go back to reference Noji T, Kondo S, Hirano S, Tanaka E, Suzuki O, Shichinohe T. Computed tomography evaluation of regional lymph node metastases in patients with biliary cancer. Br J Surg. 2008;95(1):92-6.CrossRefPubMed Noji T, Kondo S, Hirano S, Tanaka E, Suzuki O, Shichinohe T. Computed tomography evaluation of regional lymph node metastases in patients with biliary cancer. Br J Surg. 2008;95(1):92-6.CrossRefPubMed
32.
go back to reference Elsholtz FHJ, Asbach P, Haas M, Becker M, Beets-Tan RGH, Thoeny HC, et al. Introducing the Node Reporting and Data System 1.0 (Node-RADS): a concept for standardized assessment of lymph nodes in cancer. Eur Radiol. 2021;31(8):6116-24. Elsholtz FHJ, Asbach P, Haas M, Becker M, Beets-Tan RGH, Thoeny HC, et al. Introducing the Node Reporting and Data System 1.0 (Node-RADS): a concept for standardized assessment of lymph nodes in cancer. Eur Radiol. 2021;31(8):6116-24.
33.
go back to reference Adachi T, Eguchi S, Beppu T, Ueno S, Shiraishi M, Okuda K, et al. Prognostic Impact of Preoperative Lymph Node Enlargement in Intrahepatic Cholangiocarcinoma: A Multi-Institutional Study by the Kyushu Study Group of Liver Surgery. Ann Surg Oncol. 2015;22(7):2269-78.CrossRefPubMed Adachi T, Eguchi S, Beppu T, Ueno S, Shiraishi M, Okuda K, et al. Prognostic Impact of Preoperative Lymph Node Enlargement in Intrahepatic Cholangiocarcinoma: A Multi-Institutional Study by the Kyushu Study Group of Liver Surgery. Ann Surg Oncol. 2015;22(7):2269-78.CrossRefPubMed
34.
go back to reference Braden B, Faust D, Ignee A, Schreiber D, Hirche T, Dietrich CF. Clinical relevance of perihepatic lymphadenopathy in acute and chronic liver disease. J Clin Gastroenterol. 2008;42(8):931-6.CrossRefPubMed Braden B, Faust D, Ignee A, Schreiber D, Hirche T, Dietrich CF. Clinical relevance of perihepatic lymphadenopathy in acute and chronic liver disease. J Clin Gastroenterol. 2008;42(8):931-6.CrossRefPubMed
35.
go back to reference King MJ, Hectors S, Lee KM, Omidele O, Babb JS, Schwartz M, et al. Outcomes assessment in intrahepatic cholangiocarcinoma using qualitative and quantitative imaging features. Cancer Imaging. 2020;20(1):43.CrossRefPubMedPubMedCentral King MJ, Hectors S, Lee KM, Omidele O, Babb JS, Schwartz M, et al. Outcomes assessment in intrahepatic cholangiocarcinoma using qualitative and quantitative imaging features. Cancer Imaging. 2020;20(1):43.CrossRefPubMedPubMedCentral
36.
go back to reference Yoh T, Hatano E, Seo S, Terajima H, Uchida Y, Taura K, et al. Preoperative criterion identifying a low-risk group for lymph node metastasis in intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2018;25(6):299-307.CrossRefPubMed Yoh T, Hatano E, Seo S, Terajima H, Uchida Y, Taura K, et al. Preoperative criterion identifying a low-risk group for lymph node metastasis in intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 2018;25(6):299-307.CrossRefPubMed
37.
go back to reference Yamashita YI, Wang H, Kurihara T, Tsujita E, Nishie A, Imai K, et al. Clinical Significances of Preoperative Classification of Intrahepatic Cholangiocarcinoma: Different Characteristics of Perihilar vs. Peripheral ICC. Anticancer Res. 2016;36(12):6563-9.CrossRefPubMed Yamashita YI, Wang H, Kurihara T, Tsujita E, Nishie A, Imai K, et al. Clinical Significances of Preoperative Classification of Intrahepatic Cholangiocarcinoma: Different Characteristics of Perihilar vs. Peripheral ICC. Anticancer Res. 2016;36(12):6563-9.CrossRefPubMed
38.
39.
go back to reference Frenkel NC, Poghosyan S, Verheem A, Padera TP, Rinkes I, Kranenburg O, et al. Liver lymphatic drainage patterns follow segmental anatomy in a murine model. Sci Rep. 2020;10(1):21808.CrossRefPubMedPubMedCentral Frenkel NC, Poghosyan S, Verheem A, Padera TP, Rinkes I, Kranenburg O, et al. Liver lymphatic drainage patterns follow segmental anatomy in a murine model. Sci Rep. 2020;10(1):21808.CrossRefPubMedPubMedCentral
40.
go back to reference Kobayashi S, Nagano H, Hoshino H, Wada H, Marubashi S, Eguchi H, et al. Diagnostic value of FDG-PET for lymph node metastasis and outcome of surgery for biliary cancer. J Surg Oncol. 2011;103(3):223-9.CrossRefPubMed Kobayashi S, Nagano H, Hoshino H, Wada H, Marubashi S, Eguchi H, et al. Diagnostic value of FDG-PET for lymph node metastasis and outcome of surgery for biliary cancer. J Surg Oncol. 2011;103(3):223-9.CrossRefPubMed
Metadata
Title
Prediction of regional lymph node metastasis in intrahepatic cholangiocarcinoma: it’s not all about size
Authors
Johannes Kolck
Timo Alexander Auer
Thula Walter-Rittel
Clarissa Hosse
Aboelyazid Elkilany
Adrian Alexander Marth
Uwe Pelzer
Raphael Mohr
Felix Krenzien
Georg Lurje
Wenzel Schöning
Bernd Hamm
Dominik Geisel
Uli Fehrenbach
Publication date
24-06-2023
Publisher
Springer US
Published in
Abdominal Radiology / Issue 10/2023
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-023-03991-1

Other articles of this Issue 10/2023

Abdominal Radiology 10/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.